Trademark: 77581130
Word
SPRINT
Status
Dead
Status Code
710
Status Date
Friday, February 14, 2020
Serial Number
77581130
Registration Number
3650067
Registration Date
Tuesday, July 7, 2009
Mark Type
4000
Filing Date
Monday, September 29, 2008
Published for Opposition
Tuesday, April 21, 2009
Cancellation Date
Friday, February 14, 2020

Trademark Owner History
Celgene Corporation - Original Registrant

Classifications
42 Conducting clinical trials in the field of hematology and oncology

Trademark Events
Feb 14, 2020
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Jul 7, 2018
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jul 29, 2015
Teas Change Of Correspondence Received
Jul 24, 2014
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jul 24, 2014
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jul 24, 2014
Case Assigned To Post Registration Paralegal
Jul 8, 2014
Teas Section 8 & 15 Received
Jul 7, 2009
Registered-Principal Register
Apr 21, 2009
Published For Opposition
Apr 1, 2009
Notice Of Publication
Mar 16, 2009
Law Office Publication Review Completed
Mar 16, 2009
Approved For Pub - Principal Register
Mar 16, 2009
Examiner's Amendment Entered
Mar 13, 2009
Assigned To Lie
Mar 13, 2009
Notification Of Examiners Amendment E-Mailed
Mar 13, 2009
Examiners Amendment E-Mailed
Mar 13, 2009
Examiners Amendment -Written
Feb 20, 2009
Teas/Email Correspondence Entered
Feb 20, 2009
Correspondence Received In Law Office
Feb 20, 2009
Teas Response To Suspension Inquiry Received
Dec 1, 2008
Notification Of Letter Of Suspension E-Mailed
Dec 1, 2008
Letter Of Suspension E-Mailed
Dec 1, 2008
Suspension Letter Written
Dec 1, 2008
Examiner's Amendment Entered
Dec 1, 2008
Notification Of Examiners Amendment E-Mailed
Dec 1, 2008
Examiners Amendment E-Mailed
Dec 1, 2008
Examiners Amendment -Written
Nov 21, 2008
Notification Of Non-Final Action E-Mailed
Nov 21, 2008
Non-Final Action E-Mailed
Nov 21, 2008
Non-Final Action Written
Nov 20, 2008
Assigned To Examiner
Oct 2, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24